Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Philip, Rizzuto"'
Publikováno v:
Orbit. :1-5
Ruxolitinib is an oral Janus associated kinase (JAK) inhibitor commonly used in the treatment of primary myelofibrosis. We describe a case of an 86-year-old woman on ruxolitinib for primary myelofibrosis who presented with a three-day history of wors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::caf354c378cbe7a1426035e73bb6f4c1
https://doi.org/10.1080/01676830.2022.2109177
https://doi.org/10.1080/01676830.2022.2109177
